IR-Med Inc. (IRME)
OTCMKTS · Delayed Price · Currency is USD
0.1200
+0.0200 (20.00%)
At close: May 14, 2025

IR-Med Company Description

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications.

The company’s development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children.

IR-Med Inc. is headquartered in Rosh Pinna, Israel.

IR-Med Inc.
Country United States
Industry Medical Devices
Sector Healthcare
Employees 4
CEO Ran Ziskind

Contact Details

Address:
ZHR Industrial Zone
Rosh Pinna, Nevada 1231400
Israel
Phone 972 4 655 5054
Website ir-medical.com

Stock Details

Ticker Symbol IRME
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US46265R1032
SIC Code 3841

Key Executives

Name Position
Ran Ziskind Chief Executive Officer
Oded Bashan Co-Founder and Chairman
Aharon Klein Co-Founder, Chief Technology Officer and Director
Aharon Binur Chief Development Officer
Dr. Yaniv Cohen M.Sc., Ph.D. Co-Founder, Chief Scientific Officer and Director
Sharon Levkoviz Chief Financial Officer, Treasurer and Secretary